Datamonitor presents physician primary research on prevalence and development time of complications and comorbidities in type 2 diabetes, and insight on how treatment choices are affected in the US, Japan, France, Germany, Italy, Spain, and the UK.
Datamonitor reports physician perceptions and key opinion leader insight into unmet needs in type 2 diabetes, as well as how well marketed and late-stage pipeline classes perform in key influencing criteria for prescribing choice.
Edit my basket
© Datamonitor 2013. All rights reserved
Terms & Conditions